	Identifying hormone receptor-positive breast cancer subtypes with recurrence scores derived from pathological data without Ki-67 indices: a clinicopathological study of breast cancer survival in West Asia. Virchows Arch Hughson MD, Majid RA, Mohammed HA, Hassan RO, Muhealdeen DN, Hassan HA. PMID: 41774182 [PubMed - as supplied by publisher]
	ChatGPT Versus DeepSeek for Breast Cancer Information Retrieval: Quantitative Comparative Study. JMIR Cancer Hajjo R, Sabbah DA, Bardaweel SK. PMID: 41773687 [PubMed - in process]
	Educational Intervention to Improve Sexual Health and Quality of Life in Survivors of Breast and Gynecological Cancer: Protocol for a Mixed Methods Feasibility Study. JMIR Res Protoc Salazar Falla N, Navas Jojoa MLÁ, Lalinde Riviño JD, Escandón Bucheli A, Galindo-Sánchez JS. PMID: 41773666 [PubMed - in process]
	Nanotechnology based targeted drug delivery systems for breast cancer: challenges, recent advancement and future perspectives. Nanomedicine (Lond) Kumar S, Rathaur S, Maity D, Varshney P, Gayen JR. PMID: 41773625 [PubMed - as supplied by publisher]
	The Role of Ki-67 in Predicting Breast Cancer Survival in Indonesia: A Prospective Cohort Study. Clin Ter Yarso KY, Azmiardi A, Ardianti M, Wahyudi AZ. PMID: 41773376 [PubMed - in process]
	Interplay of iron regulatory proteins and inflammatory markers in benign and malignant ovarian cancer: A cross sectional study. Clin Ter Haritha Padannapurath M, Sudha K, Neelam MP, Sowndarya K. PMID: 41773365 [PubMed - in process]
	"Methodological Constraints and Interpretive Overreach in ESR1-Breast Cancer Association Studies: A Critical Appraisal". Health Sci Rep Tahir I, Shahbaz H. PMID: 41773216 [PubMed]
	Breast Cancer During Pregnancy and Lactation: A Five-Year Retrospective Study in Sudan. Cureus Aydrose A, Elsdaig HE, Abdalla A, Abdalla M, Alsadig F, Ahmed T, Abdallah E, Alagha A, Yousif T. PMID: 41773136 [PubMed]
	Exposure to industrial air toxics and risk of breast cancer in California: The Multiethnic Cohort Study. J Occup Environ Med Van Deventer D, Park SL, Cheng I, Wu AH, Chen Y, Yang J, Stram DO, Marchand LL, Ritz B, Heck JE. PMID: 41772764 [PubMed - as supplied by publisher]
	Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment. Trials Pop CF, Veys I, Moreau M, Paesmans M, De Azambuja E, Larsimont D, Liberale G. PMID: 41772708 [PubMed - as supplied by publisher]
	Systematic review and meta-analysis comparing perioperative outcomes of minimally invasive and open axillary lymph node dissection in breast cancer. J Robot Surg Wang R, Yu X. PMID: 41772335 [PubMed - in process]
	The Impact of Conventional Chemotherapy Regimens and Targeted Drugs on Ovarian Function in Breast Cancer Patients. Reprod Sci Haskoylu S, Sahin SB, Alt, Yildiz S, Bildik G, Benlioglu C, Turan V, Kim S, Oktem O. PMID: 41772301 [PubMed - as supplied by publisher]
	Prospective study on (18)F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma. Br J Cancer Metser U, Dayes IS, Parpia S, Eisen AF, Hodgson N, Cil TD, George R, Blanchette P, Arnaou A, Chan A, Levine MN. PMID: 41772273 [PubMed - as supplied by publisher]
	Efficacy and safety of eribulin plus gemcitabine as second-line treatment for recurrent HER2-negative breast cancer: a phase II, single-arm, open-label trial. Commun Med (Lond) Xu X, Zhong J, Lin H, Wang H, Ye J, Du C, Wang Z, Zou G, Ouyang J, Yu G, Wang Y, Li L, Xu F, Cui S, Xiao M, Peng P. PMID: 41772182 [PubMed - as supplied by publisher]
	The Gut Microbiota-Ovarian Cancer Axis: Mechanisms of Influence and Therapeutic Implications. Technol Cancer Res Treat Mao J, Bao H. PMID: 41771775 [PubMed - in process]
	Comparing the Efficacy of Various Treatment Strategies for Patients With Advanced Triple-Negative Breast Cancer: An Umbrella Review. Clin Pharmacol Ther Ma X, Jia S, Gao T, Liu J, Xin T, Liu Z, Yang Y, Xiang R, Gao M, Zhao M. PMID: 41771765 [PubMed - as supplied by publisher]
	Regulatory T Cells in Ovarian Cancer: Insights into Cancer Immunotherapy. Crit Rev Oncol Hematol Chang Y, Yu J, Qiu Z, Zhang J, Yang Z, He J, Li N, Wang H. PMID: 41771456 [PubMed - as supplied by publisher]
	Publisher Correction: Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction. Insights Imaging Cao Y, Gong X, Huang Y, Chen H, Fang J, Wang L, Li L, Tang S, Yin T, Wang X, Zhang J. PMID: 41770402 [PubMed]
	Barriers and enablers to integrating physical activity in breast cancer care: A qualitative study using the TDF and COM-B model. Support Care Cancer Piazzon N, Carrouel F, Gérard A, Ringot A, Cortet M, Verot E. PMID: 41770281 [PubMed - in process]
	Impact of Symptomatic Versus Asymptomatic Breast Cancer Recurrence on Survival: A Retrospective Study of 238 Patients. Cureus Yamamura J, Inoue S, Yoshioka M, Kamigaki S. PMID: 41769561 [PubMed]

Articles 1 - 20 / 325074

Page 1 of 16254



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy